Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Heidi Kabler"'
Publikováno v:
Antimicrobial Stewardship & Healthcare Epidemiology, Vol 2 (2022)
Outpatient antibiotic use increases during winter months, but information on temporal changes in inpatient antibiotic use in US hospitals is limited. The use of certain inpatient antibiotics, including extended-spectrum cephalosporins, macrolides, an
Externí odkaz:
https://doaj.org/article/35285f226e964c4091135d0ec8f366f5
Autor:
Amy Meehan, Rebecca Uth, Emily A. Gadbois, Rosa R. Baier, Stefan Gravenstein, Andrew R. Zullo, Heidi Kabler, Matthew M. Loiacono, Barbara H. Bardenheier
Publikováno v:
Journal of the American Geriatrics Society.
Publikováno v:
Open Forum Infectious Diseases. 9
Background Viral infections are often treated with empiric antibiotics due to suspected bacterial coinfections, leading to antibiotic overuse. We aimed to describe antibiotic resistance (ABR) trends and their association with the influenza season in
Autor:
Naim Alkhouri, Robert Herring, Heidi Kabler, Zeid Kayali, Tarek Hassanein, Anita Kohli, Ryan S. Huss, Yanni Zhu, Andrew N. Billin, Lars Holm Damgaard, Kristine Buchholtz, Mette Skalshøi Kjær, Clare Balendran, Robert P. Myers, Rohit Loomba, Mazen Noureddin
Publikováno v:
Journal of hepatology. 77(3)
Non-alcoholic steatohepatitis (NASH) is associated with increased risk of liver-related and cardiovascular morbidity and mortality. Given the complex pathophysiology of NASH, combining therapies with complementary mechanisms may be beneficial. This t
Autor:
Amy Meehan, Emily Gadbois, Rebecca Uth, Rosa Baier, Stefan Gravenstein, Andrew Zullo, Heidi Kabler, Matthew Loiacono, Barbara Bardenheier
Publikováno v:
Journal of the American Medical Directors Association. 23:e12
Autor:
Amy Meehan, Rebecca Uth, Emily Gadbois, Rosa Baier, Stefan Gravenstein, Andrew Zullo, Heidi Kabler, Matthew Loiacono, Barbara Bardenheier
Publikováno v:
Journal of the American Medical Directors Association. 23:B18
Publikováno v:
Journal of the American Medical Directors Association. 23:B17
Autor:
Ilan Wapinski, Brian B. Borg, Naim Alkhouri, G. Mani Subramanian, Rajalakshmi Iyer, Anita Kohli, John E. Poulos, Bal R. Bhandari, Tarek Hassanein, Kris V. Kowdley, Aasim Sheikh, Mazen Noureddin, Zachary Goodman, Chuhan Chung, Andrew H. Beck, Keyur Patel, Ryan S Huss, Jen Chieh Chuang, Robert P. Myers, Guy Neff, Reem Ghalib, Atlas Investigators, Vincent Wai-Sun Wong, Catherine Jia, Mitchell L. Shiffman, Rohit Loomba, Magdy Elkhashab, Heidi Kabler, Murray B. Resnick, D. Ding, Nadege Gunn, Stephen H. Caldwell, Ziad Younes, Simone I. Strasser, Peter Ruane
Publikováno v:
Hepatology (Baltimore, Md.)References. 73(2)
Background and aims Advanced fibrosis attributable to NASH is a leading cause of end-stage liver disease. Approach and results In this phase 2b trial, 392 patients with bridging fibrosis or compensated cirrhosis (F3-F4) were randomized to receive pla
Autor:
Catherine Vincent, James K. Chen, François Leylavergne, Heidi Kabler, Frederick Wittke, Guennaëlle Dieppois, Barry Heller, J Scott Overcash
Publikováno v:
Antimicrobial agents and chemotherapy. 64(10)
Afabicin (formerly Debio 1450, AFN-1720) is a prodrug of afabicin desphosphono, an enoyl-acyl carrier protein reductase (FabI) inhibitor, and is a first-in-class antibiotic with a novel mode of action to specifically target fatty acid synthesis in St
Publikováno v:
Open Forum Infectious Diseases
Background Inappropriate antibiotic (AB) use for viral respiratory illnesses remains widespread in the United States (US) with strong seasonal fluctuations. In contrast to outpatient AB use, the seasonality inpatient AB utilization (IAU) and its corr